Literature DB >> 9364

Factors influencing the immune enhancement of intrapulmonary bactericidal mechanisms.

G J Jakab.   

Abstract

The effect of specific immunization on the antibacterial defense mechanisms of the murine lung was assessed against Streptococcus pneumoniae, Staphylococcus aureus, Staphylococcus aureus (Smith), Serratia marcescens, Klebsiella pneumoniae, Proteus mirabilis, and Pseudomonas aeruginosa. Immunization by aerosol inhalation significantly enhanced the intrapulmonary killing of Pseudomonas aeruginosa and Proteus mirabilis but not the remaining organisms. With P. mirabilis, systemic immunization induced higher titers of specific serum agglutinins as compared with local respiratory tract immunization; however, local immunization was more effective in enhancing pulmonary bactericidal activity than was parenteral vaccination. Passive immunity against P. mirabilis or aerogenic challenge with preopsonized P. mirabilis significantly enhanced intrapulmonary killing of the homologous organism. With S. aureus, pulmonary bactericidal activity was not accelerated by aerosol challenge with the preopsonized organism, nor was it accelerated in passively immunized mice. These data demonstrate that the immune enhancement of pulmonary bactericidal activity is governed by the bacterium used for challenge and the route of immunization. The results further demonstrate that with P. mirabilis, antibody-mediated mechanisms are involved in the immune enhancement of pulmonary bactericidal activity.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 9364      PMCID: PMC420896          DOI: 10.1128/iai.14.2.389-398.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Pulmonary host defenses. II. Interaction of respiratory antibodies with Pseudomonas aeruginosa and alveolar macrophages.

Authors:  H Y Reynolds; R E Thompson
Journal:  J Immunol       Date:  1973-08       Impact factor: 5.422

2.  Pulmonary host defenses. I. Analysis of protein and lipids in bronchial secretions and antibody responses after vaccination with pseudomonas aeruginosa.

Authors:  H Y Reynolds; R E Thompson
Journal:  J Immunol       Date:  1973-08       Impact factor: 5.422

3.  Sources of variance in the measurement of intrapulmonary killing of bacteria.

Authors:  D Ruppert; G J Jakab; D L Sylwester; G M Green
Journal:  J Lab Clin Med       Date:  1976-03

4.  Pulmonary host defenses in rabbits after immunization with Pseudomonas antigens: the interaction of bacteria, antibodies, macrophages, and lymphocytes.

Authors:  H Y Reynolds
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

5.  Activation of alveolar macrophages after lower respiratory tract infection.

Authors:  J D Johnson; W L Hand; N L King; C G Hughes
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

6.  The effect of Sendai virus infection on bactericidal and transport mechanisms of the murine lung.

Authors:  G J Jakab; G M Green
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

7.  Murine pulmonary alveolar macrophages: rates of bacterial ingestion, inactivation, and destruction.

Authors:  M Kim; E Goldstein; J P Lewis; W Lippert; D Warshauer
Journal:  J Infect Dis       Date:  1976-03       Impact factor: 5.226

8.  Cell-mediated immunity after bacterial infection of the lower respiratory tract.

Authors:  J R Cantey; W L Hand
Journal:  J Clin Invest       Date:  1974-11       Impact factor: 14.808

9.  Development of cellular and humoral immunity in the respiratory tract of rabbits to Pseudomonas lipopolysaccharide.

Authors:  H Y Reynolds; R E Thompson; H B Devlin
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

10.  Use of technetium ( 99m Tc) as a bacterial label in lung clearance studies.

Authors:  W G Johanson; M G Kennedy; F J Bonte
Journal:  Appl Microbiol       Date:  1973-04
View more
  14 in total

1.  Early clearance of pneumococci from the lungs of decomplemented rats.

Authors:  S R Rehm; J D Coonrod
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

2.  Nonphagocytic clearance of Staphylococcus aureus from murine lungs.

Authors:  K M Nugent; E L Pesanti
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

3.  The effect of intraalveolar fluid on lung bacterial clearance.

Authors:  G D Harris; D E Woods; R Fine; W G Johanson
Journal:  Lung       Date:  1980       Impact factor: 2.584

4.  Aerosol vaccination of calves with pasteurella haemolytica against experimental respiratory disease.

Authors:  K W Jericho; E V Langford
Journal:  Can J Comp Med       Date:  1982-07

5.  Chronic glucocorticosteroid therapy impairs staphylococcal clearance from murine lungs.

Authors:  K M Nugent; E L Pesanti
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

6.  Comparative role of complement in pneumococcal and staphylococcal pneumonia.

Authors:  J D Coonrod; K Yoneda
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

7.  Appearance of specific antibody-bearing cells in human bronchial mucosa after local immunization with bacterial vaccine.

Authors:  F Latil; D Vervloet; P Casanova; L Garbe; P Fuentes; N Wierzbicki; J Charpin
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

8.  Alveolar macrophage ingestion and phagosome-lysosome fusion defect associated with virus pneumonia.

Authors:  G J Jakab; G A Warr; P L Sannes
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

9.  Impaired lung defenses against Staphylococcus aureus in mice with hereditary deficiency of the fifth component of complement.

Authors:  M C Cerquetti; D O Sordelli; R A Ortegon; J A Bellanti
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

10.  Enhancement of Pseudomonas aeruginosa lung clearance after local immunization with a temperature-sensitive mutant.

Authors:  D O Sordelli; M C Cerquetti; A M Hooke; J A Bellanti
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.